What is Nemaura Medical Interest Expense?
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Nemaura Medical's interest expense for the
three
months ended in Dec. 2023 was $ -1.93 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-5.67 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Nemaura Medical's Operating Income for the
three
months ended in Dec. 2023 was $ -1.54 Mil. Nemaura Medical's Interest Expense for the
three
months ended in Dec. 2023 was $ -1.93 Mil.
Nemaura Medical did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Nemaura Medical Interest Expense Calculation
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.67 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nemaura Medical (OTCPK:NMRD) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Nemaura Medical's Interest Expense for the
three
months ended in Dec. 2023 was $-1.93 Mil. Its
Operating Income
for the
three
months ended in Dec. 2023 was $-1.54 Mil. And its Long-Term Debt & Capital Lease Obligation for the
three
months ended in Dec. 2023 was $0.00 Mil.
Nemaura Medical's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as
| Nemaura Medical did not have earnings to cover the interest expense. |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Nemaura Medical (Nemaura Medical) Business Description
Traded in Other Exchanges
N/A
Address
57 West 57th Street, New York, NY, USA, 10019
Nemaura Medical Inc is a medical technology company developing sugarBEAT as a non-invasive, affordable, and flexible Continuous Glucose Monitor (CGM) designed for people with diabetes and pre-diabetics to manage their glucose levels. Insulin users can adjunctively use sugarBEAT when calibrated with a finger-stick glucose reading. SugarBEAT consists of a daily disposable adhesive skin patch connected to a rechargeable transmitter with an app displaying glucose readings at five-minute intervals for periods up to 24 hours.
Executives
| Bashir Timol |
director, 10 percent owner, officer: Chief Business Officer |
C/O ONE E GROUP LIMITED, UNIT 3A, SPRINGFIELD COURT, SUMMERFIELD ROAD, BOLTON X0 BL32NT |
| Chowdhury Dewan Fazlul Hoque |
director, 10 percent owner, officer: CEO & President |
CHAMWOOD BUILDING, HOLYWELL PARK, ASHBURY ROAD, LOUGHBOROUGH LEICS X0 LE113AQ |
| Salim Natha |
director |
LOUGHBOROUGHUNIVERSITYSCIENCE&ENTERPRISE, PARKS, 5 OAKWOOD DRIVE, LOUGHBOROUGH, LEICESTERSHIRE X0 LE113QF |
| Justin James Mclarney |
officer: Chief Financial Officer |
C/O NEMAURA MEDICAL INC., 57 WEST 57TH STREET, MANHATTAN NY 10019 |
| Sufyan Ismail |
10 percent owner |
C/O ONE E GROUP LIMITED, UNIT 3A, SPRINGFIELD COURT, SUMMERFIELD ROAD, BOLTON X0 BL32NT |
| Thomas Peter Moore |
director |
C/O NEMAURA MEDICAL, INC., 57 WEST 57TH STREET, MANHATTAN NY 10019 |
| Timothy Christopher Johnson |
director |
C/O NEMAURA MEDICAL INC., 57 WEST 57TH STREET, MANHATTAN NY 10019 |
| Iain Anderson |
officer: CFO |
LOUGHBOROUGHUNIVERSITYSCIENCE&ENTERPRISE, PARKS, 5 OAKWOOD DRIVE, LOUGHBOROUGH, LEICESTERSHIRE X0 LE113QF |
| Kathryn Farrar |
officer: Director of Finance |
C/O ONE E GROUP LIMITED, UNIT 3A, SPRINGFIELD COURT, SUMMERFIELD ROAD, BOLTON X0 BL32NT |
| Julie Pomeroy |
officer: Director of Finance |
C/O ONE E GROUP LIMITED, UNIT 3A, SPRINGFIELD COURT, SUMMERFIELD ROAD, BOLTON X0 BL32NT |
| Richard Toon |
officer: Technical & Bus. Dev. Manager |
C/O ONE E GROUP LIMITED, UNIT 3A, SPRINGFIELD COURT, SUMMERFIELD ROAD, BOLTON X0 BL32NT |
Nemaura Medical (Nemaura Medical) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NMRD has been successfully added to your 